参考文献/References:
[1] 李子良,蔡铭泉,吴 丹.三阴乳腺癌患者新辅助化疗疗效及预后评价[J]. 中国肿瘤临床与康复,2017,24(1):43-45.
Li ZL,Cai MQ,Wu D.Efficacy and prognosis of neoadjuvant chemotherapy in patients with triple negative breast cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation,2017,24(1):43-45.
[2] 高翠红,肖凤艳,高庆双,等.乳腺癌患者的免疫功能分析[J].实用预防医学,2015,22(2):242-244.
Gao CH,Xiao FY,Gao QS,et al.Analysis of immune function in breast cancer patients[J].Practical Preventive Medicine,2015,22(2):242-244.
[3] 唐凤娟,许三鹏,王国平,等.Wnt5a和Wnt11在肺癌中的表达及意义[J].临床与实验病理学杂志,2017,33(10):1082-1086.
Tang FJ,Xu SP,Wang GP,et al.Expression of Wn-t5a and Wnt11 in lung cancer and their significance[J].Journal of Clinical and Experimental Pathology,2017,33(10):1082-1086.
[4] 王 一,廖宏伟,宋 扬,等.三阴性乳腺癌患者新辅助化疗过程中血清维生素D、维生素B12、叶酸水平变化与化疗效果的关系[J].山东医药,2017,57(27):96-98.
Wang Yi,Liao HW,Song Y,et al.The relationship between serum vitamin D,vitamin B12,folic acid level and the effect of chemotherapy in three patients with negative breast cancer[J].Shandong Medicine Journal,2017,57(27):96-98.
[5] 何建明,朱少芳,黄 伟,等.25-羟基维生素D、血钙、钙敏感受体及E-钙粘蛋白与乳腺癌发生风险的病例对照研究[J].广东医学,2014,35(2):213-216.
He JM,Zhu SF,Huang W,et al.A case-control study of 25-hydroxyvitamin D,blood calcium,calcium sensitive receptors,E-cadherin and the risk of breast cancer[J].Guangdong Medicine Journal,2014,35(2):213-216.
[6] 李冰燕,童 建,张增利.1,25二羟基维生素D3对乳腺癌细胞放射敏感性的影响[J].肿瘤,2007,27(8):620-622,627.
Li BY,Tong J,Zhang ZL.Effect of 1,25(OH)2 vitamin D3 on thesensitivities of breast cancer cells to ionizing radiation[J].Tumor,2007,27(8):620-622,627.
[7] 朱小丽,苏国新,马红芳,等.大株红景天注射液对三阴性乳腺癌患者生活质量及免疫功能的影响[J].时珍国医国药,2017,28(11):2690-2692.
Zhu XL,Su GX,Ma HF,et al.The influence of Sofren injection on the quality of life and immune function of triple negative breast cancer patients[J].Lishizhen Medicine and Materia Medica Research,2017,28(11):2690-2692.
[8] 杨 辉,江 皓.新辅助TAC化疗对早期乳腺癌患者疗效、细胞免疫功能和Ki-67的影响[J].中华全科医学,2017,15(4):555-557,671.
Yang H,Jiang H.Influence of neoadjuvant chemotherapy of TAC on curative effect,cellular immunity and Ki-67 expression in early breast cancer patients[J].Chinese Journal of General Practice,2017,15(4):555-557,671.
[9] 王洪源,钱俊峰.老年支气管哮喘患者免疫功能、炎症因子和25-羟维生素D3的水平[J].中国老年学杂志,2018,38(2):367-369.
Wang HY,Qian JF.Immune function,inflammatory factors and 25-hydroxyl vitamin D3 levels in elderly patients with bronchial asthma[J].ChineseJournal of Gerontology,2018,38(2):367-369.
[10] 黄利华,胡庆兰,李伟明,等.孕乳期补充维生素D对仔鼠免疫球蛋白及T细胞的影响[J].中国妇幼保健,2017,32(16):3919-3921.
Huang LH,Hu QL,Li WM,et al.Effects of vitamin D supplementation duringpregnancy and lactation on immunoglobulin and T cells in offspring rats[J].Maternal and Child Health Care of China,2017,32(16):3919-3921.
[11] 牛福勇,李福荣.维生素D在来曲唑干预绝经后雌激素受体阳性乳腺癌患者中的作用及临床意义[J].中国实验诊断学,2017,21(7):1165-1168.
Niu FY,Li FR.Clinical effect of vitamin D in estrogen receptor-positivebreast cancer patients treated with letrozole[J].Chinese Journal of Laboratory Diagnosis,2017,21(7):1165-1168.
[12] 刘艳平,张丽萍.早期补充维生素D对早产儿感染性疾病的IL-2,IL-4及免疫球蛋白的影响[J].国际检验医学杂志,2018,39(4):422-425.
Liu YP,Zhang LP.The effect of early vitamin D supplementation on IL-2,IL-4 and immunoglobulin in premature infants with infectious diseases[J].Int J Lab Med,2018,39(4):422-425.
[13] 朱慧花,赵 琳.维生素D与免疫功能的研究[J].医学综述,2013,19(5):820-822.
Zhu HH,Zhao L.The research on Vitamin D and immunity[J].Medical Review,2013,19(5):820-822.
[14] 王维杰,张光辉,励新健,等.肺癌患者术前血清维生素D水平与免疫功能及术后合并肺炎发生率的相关性研究[J].浙江临床医学,2018,20(2):239-240,243.
Wang WJ,Zhang GH,Li XJ,et al.Correlation of serum vitamin D levels with immune function and the incidence of pneumonia after operation in patients with lung cancer[J].Zhejiang Clinical Medicine,2018,20(2):239-240,243.
[15] 崔 明,王 杉,叶颖江,等.肿瘤负荷对大肠癌患者外周血T细胞分化的影响[J].中华医学杂志,2007,87(1):16-19.
Cui M,Wang S,Ye YJ,et al.Effect of tumor burden on differentiation ofT lymphocytes in the peripheral blood of patients with colorectal cancer[J].National Medical Journal of China,2007,87(1):16-19.
[16] 王 一,廖宏伟,宋 扬.三阴型乳腺癌患者血清Vit D水平与瘤组织Ki-67,p53蛋白表达变化及其相关性[J].山东医药,2018,58(11):83-85.
Wang Y, Liao HW, Song Y.The relationship between serum vitamin D and Ki-67,p53 in three patients with negative breast cancer[J].Shandong Medicine,2018,58(11):83-85.